{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:25:08Z","timestamp":1790735108683,"version":"4.1.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T00:00:00Z","timestamp":1551916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T00:00:00Z","timestamp":1551916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00059-019-4795-6","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T08:22:57Z","timestamp":1551946977000},"page":"130-137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension","Bedeutsame inflammatorische Signalwege f\u00fcr vaskul\u00e4res Remodeling bei pulmonaler Hypertonie"],"prefix":"10.1007","volume":"44","author":[{"given":"E. M.","family":"Berghausen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Feik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zierden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vantler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rosenkranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,7]]},"reference":[{"issue":"37","key":"4795_CR1","first-page":"67","volume":"2016","author":"N Gali\u00e8","year":"2015","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL et\u00a0al (2015) ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart\u00a0J 2016(37):67\u2013119","journal-title":"Eur Heart J"},{"key":"4795_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","volume":"4","author":"MM Hoeper","year":"2016","unstructured":"Hoeper MM, Humbert M, Souza R et\u00a0al (2016) A global view of pulmonary hypertension. Lancet Respir Med 4:306\u2013322","journal-title":"Lancet Respir Med"},{"issue":"1","key":"4795_CR3","doi-asserted-by":"publisher","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","volume":"53","author":"G Simmoneau","year":"2019","unstructured":"Simmoneau G, Montani D, Celermayer DS et\u00a0al (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir\u00a0J 53(1):1801913","journal-title":"Eur Respir J"},{"issue":"1","key":"4795_CR4","doi-asserted-by":"publisher","first-page":"1801887","DOI":"10.1183\/13993003.01887-2018","volume":"53","author":"M Humbert","year":"2019","unstructured":"Humbert M, Guignabert C, Bonnet S et\u00a0al (2019) Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir\u00a0J 53(1):1801887","journal-title":"Eur Respir J"},{"key":"4795_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijcard.2018.09.070","volume":"272","author":"A Olschewski","year":"2018","unstructured":"Olschewski A, Berghausen EM, Eichstaedt CA et\u00a0al (2018) Pathobiology, pathology and genetics of pulmonary hypertension: update from the Cologne Consensus Conference 2018. Int J Cardiol 272:4\u201310","journal-title":"Int J Cardiol"},{"key":"4795_CR6","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1172\/JCI60658","volume":"122","author":"M Rabinovitch","year":"2012","unstructured":"Rabinovitch M (2012) Molecular pathogenesis of pulmonary arterial hypertension. J\u00a0Clin Invest 122:4306\u20134313","journal-title":"J Clin Invest"},{"key":"4795_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00392-014-0765-4","volume":"104","author":"S Rosenkranz","year":"2015","unstructured":"Rosenkranz S (2015) Pulmonary hypertension 2015: current definitions, terminology, and novel treatment options. Clin Res Cardiol 104:197\u2013207","journal-title":"Clin Res Cardiol"},{"key":"4795_CR8","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1161\/CIRCULATIONAHA.114.006974","volume":"130","author":"M Humbert","year":"2014","unstructured":"Humbert M, Lau EM, Montani D, Jais X, Sitbon O, Simonneau G (2014) Advances in therapeutic interventions for patients with pulmonary arterial hypertension. Circulation 130:2189\u20132208","journal-title":"Circulation"},{"key":"4795_CR9","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","volume":"37","author":"S Rosenkranz","year":"2016","unstructured":"Rosenkranz S, Gibbs JSR, Wachter R et\u00a0al (2016) Left ventricular heart failure and pulmonary hypertension. Eur Heart\u00a0J 37:942\u2013954","journal-title":"Eur Heart J"},{"key":"4795_CR10","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1016\/j.jacc.2016.09.942","volume":"68","author":"TR Assad","year":"2016","unstructured":"Assad TR, Hemnes AR, Larkin EK et al (2016) Clinical and biological insights into combined post- and pre-capillary pulmonary hypertension. J\u00a0Am Coll Cardiol 68:2525\u20132536","journal-title":"J Am Coll Cardiol"},{"key":"4795_CR11","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/nrd3297","volume":"9","author":"F Grimminger","year":"2010","unstructured":"Grimminger F, Schermuly RT, Ghofrani HA (2010) Targeting non-malignant disorders with tyrosine kinase inhibitors. Nat Rev Drug Discov 9:956\u2013970","journal-title":"Nat Rev Drug Discov"},{"key":"4795_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/978-3-662-45805-1_16","volume":"218","author":"E Berghausen","year":"2013","unstructured":"Berghausen E, ten Freyhaus H, Rosenkranz S (2013) Targeting of platelet-derived growth factor signaling in pulmonary arterial hypertension. Handb Exp Pharmacol 218:381\u2013408","journal-title":"Handb Exp Pharmacol"},{"key":"4795_CR13","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jacbts.2016.11.005","volume":"1","author":"JJ Ryan","year":"2016","unstructured":"Ryan JJ (2016) Tyrosine kinase inhibitors in pulmonary\u00a0vascular disease. Jacc Basic Transl Sci 1:684\u2013686","journal-title":"Jacc Basic Transl Sci"},{"key":"4795_CR14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/path.5044","volume":"244","author":"S Crnkovic","year":"2018","unstructured":"Crnkovic S, Marsh LM, El Agha E et\u00a0al (2018) Resident cell lineages are preserved in pulmonary vascular remodeling. J\u00a0Pathol 244:485\u2013498","journal-title":"J Pathol"},{"issue":"1","key":"4795_CR15","doi-asserted-by":"publisher","first-page":"1701214","DOI":"10.1183\/13993003.01214-2017","volume":"51","author":"LM Marsh","year":"2018","unstructured":"Marsh LM, Jandl K, Gr\u00fcnig G et\u00a0al (2018) The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension. Eur Respir\u00a0J 51(1):1701214","journal-title":"Eur Respir J"},{"key":"4795_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1161\/CIRCRESAHA.113.301141","volume":"115","author":"M Rabinovitch","year":"2014","unstructured":"Rabinovitch M, Guignabert C, Humbert M, Nicolls MR (2014) Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res 115:165\u2013175","journal-title":"Circ Res"},{"key":"4795_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1378\/chest.11-0793","volume":"141","author":"LC Price","year":"2012","unstructured":"Price LC, Wort SJ, Perros F et\u00a0al (2012) Inflammation in pulmonary arterial hypertension. Chest 141:210\u2013221","journal-title":"Chest"},{"key":"4795_CR18","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1164\/rccm.201202-0335OC","volume":"186","author":"R Savai","year":"2012","unstructured":"Savai R, Pullamsetti SS, Kolbe J et\u00a0al (2012) Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 186:897\u2013908","journal-title":"Am J Respir Crit Care Med"},{"key":"4795_CR19","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00109-011-0762-2","volume":"9","author":"G Sutendra","year":"2011","unstructured":"Sutendra G, Dromparis P, Bonnet S et\u00a0al (2011) Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNF\u03b1 contributes to the pathogenesis of pulmonary arterial hypertension. J\u00a0Mol Med 9:771\u2013783","journal-title":"J. Mol. Med."},{"key":"4795_CR20","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1183\/09031936.03.00038903","volume":"22","author":"P Dorfm\u00fcller","year":"2003","unstructured":"Dorfm\u00fcller P, Perros F, Balabanian K, Humbert M (2003) Inflammation in pulmonary arterial hypertension. Eur Respir\u00a0J 22:358\u2013363","journal-title":"Eur Respir J"},{"key":"4795_CR21","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1164\/rccm.201008-1303OC","volume":"183","author":"T Thenappan","year":"2011","unstructured":"Thenappan T, Goel A, Marsboom et\u00a0al (2011) A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion. Am J Respir Crit Care Med 183:1080\u20131091","journal-title":"Am J Respir Crit Care Med"},{"key":"4795_CR22","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2353\/ajpath.2006.050599","volume":"168","author":"MG Frid","year":"2006","unstructured":"Frid MG, Brunetti JA, Burke DL et al (2006) Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a\u00a0monocyte\/macrophage lineage. Am J Pathol 168:659\u2013669","journal-title":"Am J Pathol"},{"key":"4795_CR23","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1161\/CIRCULATIONAHA.110.978627","volume":"123","author":"E Vergadi","year":"2011","unstructured":"Vergadi E, Chang MS, Lee C et al (2011) Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension. Circulation 123:1986\u20131995","journal-title":"Circulation"},{"key":"4795_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/2045-8932.109915","volume":"3","author":"KM Porter","year":"2013","unstructured":"Porter KM, Walp ER, Elms SC et al (2013) Human immunodeficiency virus-1 transgene expression increases pulmonary vascular resistance and exacerbates hypoxia-induced pulmonary hypertension development. Pulm Circ 3:58\u201367","journal-title":"Pulm Circ"},{"key":"4795_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4103\/2045-8932.97613","volume":"2","author":"ME Yeager","year":"2012","unstructured":"Yeager ME, Reddy MB, Nguyen CM et\u00a0al (2012) Activation of the unfolded protein response is associated with pulmonary hypertension. Pulm Circ 2:229\u2013240","journal-title":"Pulm Circ"},{"key":"4795_CR26","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/CIRCRESAHA.110.236927","volume":"109","author":"R Tamosiuniene","year":"2011","unstructured":"Tamosiuniene R, Tian W, Dhillon G et\u00a0al (2011) Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension. Circ Res 109:867\u2013879","journal-title":"Circ Res"},{"key":"4795_CR27","doi-asserted-by":"publisher","first-page":"200ra117","DOI":"10.1126\/scitranslmed.3006674","volume":"5","author":"W Tian","year":"2013","unstructured":"Tian W, Jiang X, Tamosiuniene R et\u00a0al (2013) Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension. Sci Transl Med 5:200ra117","journal-title":"Sci Transl Med"},{"key":"4795_CR28","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.4049\/jimmunol.1100479","volume":"187","author":"M Li","year":"2011","unstructured":"Li M, Riddle SR, Frid MG et\u00a0al (2011) Emergence of fibroblasts with a\u00a0proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension. J\u00a0Immunol 187:2711\u20132722","journal-title":"J Immunol"},{"key":"4795_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1084\/jem.20111741","volume":"211","author":"H Sawada","year":"2014","unstructured":"Sawada H, Saito T, Nickel NP et al (2014) Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension. J\u00a0Exp Med 211:263\u2013280","journal-title":"J Exp Med"},{"key":"4795_CR30","doi-asserted-by":"publisher","first-page":"906","DOI":"10.4049\/jimmunol.1200257","volume":"189","author":"CH Serezani","year":"2012","unstructured":"Serezani CH, Kane S, Collins L et al (2012) Macrophage dectin-1 expression is controlled by leukotriene B4 via a\u00a0GM-CSF\/PU.1 axis. J\u00a0Immunol 189:906\u2013915","journal-title":"J Immunol"},{"key":"4795_CR31","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica A, Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. J\u00a0Clin Invest 122:787\u2013795","journal-title":"J Clin Invest"},{"key":"4795_CR32","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.ajpath.2011.05.051","volume":"179","author":"YM Kim","year":"2011","unstructured":"Kim YM, Haghighat L, Spiekerkoetter E et\u00a0al (2011) Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesions. Am J Pathol 179:1560\u20131572","journal-title":"Am J Pathol"},{"key":"4795_CR33","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1161\/hc0402.102866","volume":"105","author":"SH Zaidi","year":"2002","unstructured":"Zaidi SH, You XM, Ciura S et\u00a0al (2002) Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension. Circulation 105:516\u2013521","journal-title":"Circulation"},{"key":"4795_CR34","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/76282","volume":"6","author":"KN Cowan","year":"2000","unstructured":"Cowan KN, Heilbut A, Humpl T et\u00a0al (2000) Complete reversal of fatal pulmonary hypertension in rats by a\u00a0serine elastase inhibitor. Nat Med 6:698\u2013702","journal-title":"Nat Med"},{"key":"4795_CR35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/(SICI)1097-4652(199801)174:1<78::AID-JCP9>3.0.CO;2-D","volume":"174","author":"K Thompson","year":"1998","unstructured":"Thompson K, Kobayashi J, Childs T et al (1998) Endothelial and serum factors which include apolipoprotein A1 tether elastin to smooth muscle cells inducing serine elastase activity via tyrosine kinase-mediated transcription and translation. J\u00a0Cell Physiol 174:78\u201389","journal-title":"J Cell Physiol"},{"key":"4795_CR36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/(SICI)1097-4652(199603)166:3<495::AID-JCP4>3.0.CO;2-K","volume":"166","author":"K Thompson","year":"1996","unstructured":"Thompson K, Rabinovitch M (1996) Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular-matrix bound basic fibroblast growth factor. J\u00a0Cell Physiol 166:495\u2013505","journal-title":"J Cell Physiol"},{"key":"4795_CR37","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1172\/JCI109926","volume":"66","author":"RM Senior","year":"1980","unstructured":"Senior RM, Griffin GL, Mecham RP (1980) Chemotactic activity of elastin-derived peptides. J\u00a0Clin Invest 66:859\u2013862","journal-title":"J Clin Invest"},{"key":"4795_CR38","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0171-2985(00)80099-6","volume":"201","author":"W Vogt","year":"2000","unstructured":"Vogt W (2000) Cleavage of the fifth component of complement and generation of a\u00a0functionally active C5b6-like complex by human leukocyte elastase. Immunobiology 201:470\u2013477","journal-title":"Immunobiology"},{"key":"4795_CR39","doi-asserted-by":"publisher","first-page":"e97530","DOI":"10.1172\/jci.insight.97530","volume":"3","author":"A Klinke","year":"2018","unstructured":"Klinke A, Berghausen EM, Friedrichs K et al (2018) Myeloperoxidase aggravates pulmonary arterial hypertension by activation of vascular Rho-kinase. JCI Insight 3:e97530","journal-title":"JCI Insight"},{"key":"4795_CR40","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1172\/JCI2261","volume":"101","author":"A Bordron","year":"1998","unstructured":"Bordron A, Dueymes M, Levy Y et\u00a0al (1998) The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J\u00a0Clin Invest 101:2029\u20132035","journal-title":"J Clin Invest"},{"key":"4795_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1172\/JCI118377","volume":"97","author":"D Carvalho","year":"1996","unstructured":"Carvalho D, Savage CO, Black CM, Pearson JD (1996) IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J\u00a0Clin Invest 97:111\u2013119","journal-title":"J Clin Invest"},{"key":"4795_CR42","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/cei.12166","volume":"174","author":"SJ Arends","year":"2013","unstructured":"Arends SJ, Damoiseaux JG, Duijvestijn AM et al (2013) Immunoglobulin G anti-endothelial cell antibodies: inducers of endothelial cell apoptosis in pulmonary arterial hypertension? Clin Exp Immunol 174:433\u2013440","journal-title":"Clin Exp Immunol"},{"key":"4795_CR43","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1183\/09031936.00181410","volume":"39","author":"H Dib","year":"2012","unstructured":"Dib H, Tamby MC, Bussone G et al (2012) Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma. Eur Respir\u00a0J 39:1405\u20131414","journal-title":"Eur Respir J"},{"key":"4795_CR44","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1183\/09031936.06.00152705","volume":"28","author":"MC Tamby","year":"2006","unstructured":"Tamby MC, Humbert M, Guilpain P et al (2006) Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension. Eur Respir\u00a0J 28:799\u2013807","journal-title":"Eur Respir J"},{"key":"4795_CR45","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/S0735-1097(86)80301-1","volume":"8","author":"S Rich","year":"1986","unstructured":"Rich S, Kieras K, Hart K et\u00a0al (1986) Antinuclear antibodies in primary pulmonary hypertension. J\u00a0Am Coll Cardiol 8:1307\u20131311","journal-title":"J Am Coll Cardiol"},{"key":"4795_CR46","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1136\/thx.2004.029082","volume":"60","author":"MC Tamby","year":"2005","unstructured":"Tamby MC, Chanseaud Y, Humbert M et al (2005) Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax 60:765\u2013772","journal-title":"Thorax"},{"key":"4795_CR47","doi-asserted-by":"publisher","first-page":"e0129910","DOI":"10.1371\/journal.pone.0129910","volume":"10","author":"SH Park","year":"2015","unstructured":"Park SH, Chen WC, Durmus N et al (2015) The effects of antigen-specific IgG1 antibody for the pulmonary-hypertension-phenotype and B cells for inflammation in mice exposed to antigen and fine particles from air pollution. PLoS ONE 10:e129910","journal-title":"PLoS ONE"},{"key":"4795_CR48","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1164\/rccm.201403-0442OC","volume":"190","author":"MO Becker","year":"2014","unstructured":"Becker MO, Kill A, Kutsche M et\u00a0al (2014) Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis. Am J Respir Crit Care Med 190:808\u2013817","journal-title":"Am J Respir Crit Care Med"},{"key":"4795_CR49","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.chest.2016.01.004","volume":"149","author":"A Huertas","year":"2016","unstructured":"Huertas A, Phan C, Bordenave J et al (2016) Regulatory T cell dysfunction in idiopathic, heritable and connective tissue-associated pulmonary arterial hypertension. Chest 149:1482\u20131493","journal-title":"Chest"},{"key":"4795_CR50","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1126\/science.166.3906.753","volume":"166","author":"Y Nishizuka","year":"1969","unstructured":"Nishizuka Y, Sakakura T (1969) Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166:753\u2013755","journal-title":"Science"},{"key":"4795_CR51","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/ni1428","volume":"8","author":"JM Kim","year":"2007","unstructured":"Kim JM, Rasmussen JP, Rudensky AY (2007) Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8:191\u2013197","journal-title":"Nat Immunol"},{"key":"4795_CR52","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","volume":"22","author":"S Sakaguchi","year":"2004","unstructured":"Sakaguchi S (2004) Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531\u2013562","journal-title":"Annu Rev Immunol"},{"key":"4795_CR53","doi-asserted-by":"publisher","first-page":"572S","DOI":"10.1378\/chest.128.6_suppl.572S-a","volume":"128","author":"SM Golembeski","year":"2005","unstructured":"Golembeski SM, West J, Tada Y, Fagan KA (2005) Interleukin-6 causes mild pulmonary hypertension and augments hypoxia-induced pulmonary hypertension in mice. Chest 128:572S\u2013573S","journal-title":"Chest"},{"key":"4795_CR54","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1161\/CIRCRESAHA.117.312058","volume":"122","author":"R Tamosiuniene","year":"2018","unstructured":"Tamosiuniene R, Manouvakhova O, Mesange P et\u00a0al (2018) Dominant role for regulatory T cells in protecting females against pulmonary hypertension. Circ Res 122:1689\u20131702","journal-title":"Circ Res"},{"key":"4795_CR55","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1378\/chest.100.5.1268","volume":"100","author":"R Speich","year":"1991","unstructured":"Speich R, Jenni R, Opravil M, Pfab M, Russi EW (1991) Primary pulmonary hypertension in HIV infection. Chest 100:1268\u20131271","journal-title":"Chest"},{"key":"4795_CR56","doi-asserted-by":"publisher","first-page":"e5981","DOI":"10.1371\/journal.pone.0005981","volume":"4","author":"TR Radstake","year":"2009","unstructured":"Radstake TR, van Bon L, Broen J et\u00a0al (2009) Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a\u00a0diminished CD69 and TGFbeta expression. PLoS ONE 4:e5981","journal-title":"PLoS ONE"},{"key":"4795_CR57","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.4049\/jimmunol.182.3.1689","volume":"182","author":"M Bonelli","year":"2009","unstructured":"Bonelli M, Savitskaya A, Steiner CW et\u00a0al (2009) Phenotypic and functional analysis of CD4+ CD25\u2212 Foxp3+ T cells in patients with systemic lupus erythematosus. J\u00a0Immunol 182:1689\u20131695","journal-title":"J Immunol"},{"key":"4795_CR58","first-page":"131","volume":"2","author":"MI Covas","year":"1992","unstructured":"Covas MI, Esquerda A, Garc\u00eda-Rico A, Mahy N (1992) Peripheral blood T\u2011lymphocyte subsets in autoimmune thyroid disease. J\u00a0Investig Allergol Clin Immunol 2:131\u2013135","journal-title":"J Investig Allergol Clin Immunol"},{"key":"4795_CR59","first-page":"726","volume":"31","author":"T Mandl","year":"2004","unstructured":"Mandl T, Bredberg A, Jacobsson LT et al (2004) CD4+ T\u2011lymphocytopenia\u2014a\u00a0frequent finding in anti-SSA antibody seropositive patients with primary Sj\u00f6gren\u2019s Syndrome. J\u00a0Rheumatol 31:726\u2013728","journal-title":"J Rheumatol"},{"key":"4795_CR60","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1183\/09031936.00094706","volume":"29","author":"F Perros","year":"2007","unstructured":"Perros F, Dorfm\u00fcller P, Souza R et\u00a0al (2007) Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension. Eur Respir\u00a0J 29:462\u2013468","journal-title":"Eur Respir J"},{"key":"4795_CR61","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1164\/rccm.201105-0927OC","volume":"185","author":"F Perros","year":"2012","unstructured":"Perros F, Dorfm\u00fcller P, Montani D et\u00a0al (2012) Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 185:311\u2013321","journal-title":"Am J Respir Crit Care Med"},{"key":"4795_CR62","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.smim.2007.12.004","volume":"20","author":"DM Carragher","year":"2008","unstructured":"Carragher DM, Rangel-Moreno J, Randall TD (2008) Ectopic lymphoid tissues and local immunity. Semin Immunol 20:26\u201342","journal-title":"Semin Immunol"},{"key":"4795_CR63","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1749-6632.2009.05133.x","volume":"1183","author":"JM Damsker","year":"2010","unstructured":"Damsker JM, Hansen AM, Caspi RR (2010) Th1 and Th17 cells: adversaries and collaborators. Ann N Y Acad Sci 1183:211\u2013221","journal-title":"Ann N Y Acad Sci"},{"key":"4795_CR64","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1378\/chest.14-1678","volume":"147","author":"A Hautefort","year":"2015","unstructured":"Hautefort A, Girerd B, Montani D et al (2015) T\u2011Helper 17 cell polarization in pulmonary arterial hypertension. Chest 147:1610\u20131620","journal-title":"Chest"},{"key":"4795_CR65","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1161\/CIRCRESAHA.108.182014","volume":"104","author":"MK Steiner","year":"2009","unstructured":"Steiner MK, Syrkina OL, Kolliputi N et al (2009) Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 104:236\u2013244","journal-title":"Circ Res"},{"key":"4795_CR66","doi-asserted-by":"publisher","first-page":"L39","DOI":"10.1152\/ajplung.2001.280.1.L39","volume":"280","author":"M Fujita","year":"2001","unstructured":"Fujita M, Shannon JM, Irvin CG et al (2001) Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 280:L39\u2013L49","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4795_CR67","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1161\/CIRCULATIONAHA.113.004555","volume":"129","author":"A Huertas","year":"2014","unstructured":"Huertas A, Perros F, Tu L et\u00a0al (2014) Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a\u00a0complex interplay. Circulation 129:1332\u20131340","journal-title":"Circulation"},{"key":"4795_CR68","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1161\/CIRCULATIONAHA.113.007469","volume":"129","author":"N Ricard","year":"2014","unstructured":"Ricard N, Tu L, Le Hiress M et al (2014) Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a\u00a0source of smooth muscle-like cells in pulmonary hypertension. Circulation 129:1586\u20131597","journal-title":"Circulation"},{"key":"4795_CR69","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1086\/303059","volume":"67","author":"Z Deng","year":"2000","unstructured":"Deng Z, Morse JH, Slager SL et al (2000) Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 67:737\u2013744","journal-title":"Am J Hum Genet"},{"key":"4795_CR70","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/79226","volume":"26","author":"KB Lane","year":"2000","unstructured":"Lane KB, Machado RD, Pauciulo MW et al (2000) Heterozygous germline mutations in bmpr2, encoding a\u00a0tgf-beta receptor, cause familial primary pulmonary hypertension. Nat Genet 26:81\u201384","journal-title":"Nat Genet"},{"key":"4795_CR71","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1161\/01.CIR.0000012754.72951.3D","volume":"105","author":"C Atkinson","year":"2002","unstructured":"Atkinson C, Stewart S, Upton PD et\u00a0al (2002) Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation 105:1672\u20131678","journal-title":"Circulation"},{"key":"4795_CR72","doi-asserted-by":"publisher","first-page":"H677","DOI":"10.1152\/ajpheart.91519.2007","volume":"295","author":"Y Song","year":"2008","unstructured":"Song Y, Coleman L, Shi J et al (2008) Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice. Am J Physiol Heart Circ Physiol 295:H677\u2013H690","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4795_CR73","doi-asserted-by":"publisher","first-page":"e32468","DOI":"10.1371\/journal.pone.0032468","volume":"7","author":"EM Mushaben","year":"2012","unstructured":"Mushaben EM, Hershey GK, Pauciulo MW et al (2012) Chronic allergic inflammation causes vascular remodeling and pulmonary hypertension in BMPR2 hypomorph and wild-type mice. PLoS ONE 7:e32468","journal-title":"PLoS ONE"},{"key":"4795_CR74","doi-asserted-by":"publisher","first-page":"L604","DOI":"10.1152\/ajplung.00309.2011","volume":"302","author":"RJ Davies","year":"2012","unstructured":"Davies RJ, Holmes AM, Deighton J et al (2012) BMP type II receptor deficiency confers resistance to growth inhibition by TGF-\u03b2 in pulmonary artery smooth muscle cells: role of proinflammatory cytokines. Am J Physiol Lung Cell Mol Physiol 302:L604\u2013L615","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4795_CR75","doi-asserted-by":"publisher","first-page":"e55180","DOI":"10.1371\/journal.pone.0055180","volume":"8","author":"SH Park","year":"2013","unstructured":"Park SH, Chen WC, Hoffman C et\u00a0al (2013) Modification of hemodynamic and immune responses to exposure with a\u00a0weak antigen by the expression of a\u00a0hypomorphic BMPR2 gene. PLoS ONE 8:e55180","journal-title":"PLoS ONE"},{"key":"4795_CR76","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1164\/rccm.201408-1509OC","volume":"192","author":"E Soon","year":"2015","unstructured":"Soon E, Crosby A, Southwood M et\u00a0al (2015) Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension. Am J Respir Crit Care Med 192:859\u2013872","journal-title":"Am J Respir Crit Care Med"},{"key":"4795_CR77","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1167\/iovs.08-3135","volume":"50","author":"JG Lee","year":"2009","unstructured":"Lee JG, Kay EP (2009) Common and distinct pathways for cellular activities in FGF-2 signaling induced by IL-1beta in corneal endothelial cells. Invest Ophthalmol Vis Sci 50:2067\u20132076","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4795_CR78","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1172\/JCI35070","volume":"119","author":"M Izikki","year":"2009","unstructured":"Izikki M, Guignabert C, Fadel E et al (2009) Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents. J\u00a0Clin Invest 119:512\u2013523","journal-title":"J Clin Invest"},{"key":"4795_CR79","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nm.3040","volume":"19","author":"J Kim","year":"2013","unstructured":"Kim J, Kang Y, Kojima Y et al (2013) An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat Med 19:74\u201382","journal-title":"Nat Med"},{"key":"4795_CR80","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1465-9921-10-6","volume":"10","author":"L Savale","year":"2009","unstructured":"Savale L, Tu L, Rideau D et al (2009) Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice. Respir Res 10:6","journal-title":"Respir Res"},{"key":"4795_CR81","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1164\/rccm.201202-0309OC","volume":"186","author":"L Tu","year":"2012","unstructured":"Tu L, De Man FS, Girerd B et\u00a0al (2012) A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents. Am J Respir Crit Care Med 186:666\u2013676","journal-title":"Am J Respir Crit Care Med"},{"key":"4795_CR82","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1172\/JCI43382","volume":"121","author":"TP Alastalo","year":"2011","unstructured":"Alastalo TP, Li M, Vde PJ et al (2011) Disruption of PPAR\u03b3\/\u03b2-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival. J\u00a0Clin Invest 121:3735\u20133746","journal-title":"J Clin Invest"},{"key":"4795_CR83","doi-asserted-by":"publisher","first-page":"L1473","DOI":"10.1152\/ajplung.00197.2006","volume":"292","author":"M Hagen","year":"2007","unstructured":"Hagen M, Fagan K, Steudel W et al (2007) Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle. Am J Physiol Lung Cell Mol Physiol 292:L1473\u2013L1479","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4795_CR84","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.4049\/jimmunol.169.10.5496","volume":"169","author":"AL Hager-Theodorides","year":"2002","unstructured":"Hager-Theodorides AL, Outram SV, Shah DK et al (2002) Bone morphogenetic protein 2\/4 signaling regulates early thymocyte differentiation. J\u00a0Immunol 169:5496\u20135504","journal-title":"J Immunol"},{"key":"4795_CR85","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1164\/rccm.200608-1189OC","volume":"175","author":"L Taraseviciene-Stewart","year":"2007","unstructured":"Taraseviciene-Stewart L, Nicolls MR, Kraskauskas D et al (2007) Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling. Am J Respir Crit Care Med 175:1280\u20131289","journal-title":"Am J Respir Crit Care Med"},{"key":"4795_CR86","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/eji.200939618","volume":"40","author":"L Lu","year":"2010","unstructured":"Lu L, Ma J, Wang X et al (2010) Synergistic effect of TGF-beta superfamily members on the induction of Foxp3+ Treg. Eur J Immunol 40:142\u2013152","journal-title":"Eur J Immunol"},{"key":"4795_CR87","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1172\/JCI120415","volume":"128","author":"SS Pullamsetti","year":"2018","unstructured":"Pullamsetti SS, Seeger W, Savai R (2018) Classical IL-6 signaling: a\u00a0promising therapeutic target for pulmonary arterial hypertension. J\u00a0Clin Invest 128:1720\u20131723","journal-title":"J Clin Invest"},{"key":"4795_CR88","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1172\/JCI96462","volume":"128","author":"Y Tamura","year":"2018","unstructured":"Tamura Y, Phan C, Tu L et al (2018) Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension. J\u00a0Clin Invest 128:1956\u20131970","journal-title":"J Clin Invest"},{"key":"4795_CR89","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cyto.2015.06.018","volume":"76","author":"M Jasiewicz","year":"2015","unstructured":"Jasiewicz M, Knapp M, Waszkiewicz E et al (2015) Enhanced IL-6 trans-signaling in pulmonary arterial hypertension and its potential role in disease-related systemic damage. Cytokine 76:187\u2013192","journal-title":"Cytokine"},{"key":"4795_CR90","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1164\/rccm.201402-0322OC","volume":"192","author":"M Le Hiress","year":"2015","unstructured":"Le Hiress M, Tu L, Ricard N et\u00a0al (2015) Proinflammatory signature of the dysfunctional endothelium in pulmonary hypertension. Role of the macrophage migration inhibitory factor\/CD74 complex. Am J Respir Crit Care Med 192:983\u2013997","journal-title":"Am J Respir Crit Care Med"},{"key":"4795_CR91","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4049\/jimmunol.1303048","volume":"193","author":"KC El Kasmi","year":"2014","unstructured":"El Kasmi KC, Pugliese SC, Riddle SR et\u00a0al (2014) Adventitial fibroblasts induce a\u00a0distinct proinflammatory\/profibrotic macrophage phenotype in pulmonary hypertension. J\u00a0Immunol 193:597\u2013609","journal-title":"J Immunol"},{"key":"4795_CR92","doi-asserted-by":"publisher","first-page":"E2677","DOI":"10.1073\/pnas.1424774112","volume":"112","author":"T Hashimoto-Kataoka","year":"2015","unstructured":"Hashimoto-Kataoka T, Hosen N, Sonobe T et al (2015) Interleukin-6\/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension. Proc Natl Acad Sci Usa 112:E2677\u2013E2686","journal-title":"Proc Natl Acad Sci Usa"},{"key":"4795_CR93","first-page":"A1739","volume":"187","author":"L Tu","year":"2013","unstructured":"Tu L, Huertas A, Le Hiress M et al (2013) Mif\/cd74-dependent interleukin-6 and monocyte chemoattractant protein-1 secretion by pulmonary endothelial cells in idiopathic pulmonary hypertension. Am Thorac Soc 187:A1739","journal-title":"Am Thorac Soc"},{"key":"4795_CR94","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1165\/rcmb.2009-0379OC","volume":"44","author":"R Damico","year":"2011","unstructured":"Damico R, Simms T, Kim BS et al (2011) p53 mediates cigarette smoke-induced apoptosis of pulmonary endothelial cells: inhibitory effects of macrophage migration inhibitor factor. Am J Respir Cell Mol Biol 44:323\u2013332","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4795_CR95","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1183\/09031936.00091912","volume":"41","author":"C Guignabert","year":"2013","unstructured":"Guignabert C, Montani D (2013) Key roles of Src family tyrosine kinases in the integrity of the pulmonary vascular bed. Eur Respir\u00a0J 41:3\u20134","journal-title":"Eur Respir J"},{"key":"4795_CR96","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1084\/jem.20030286","volume":"197","author":"L Leng","year":"2003","unstructured":"Leng L, Metz CN, Fang Y et\u00a0al (2003) MIF signal transduction initiated by binding to CD74. J\u00a0Exp Med 197:1467\u20131476","journal-title":"J Exp Med"},{"key":"4795_CR97","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1183\/09031936.00211811","volume":"41","author":"C Nagaraj","year":"2013","unstructured":"Nagaraj C, Tang B, B\u00e1lint Z et\u00a0al (2013) Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries. Eur Respir\u00a0J 41:85\u201395","journal-title":"Eur Respir J"},{"key":"4795_CR98","doi-asserted-by":"publisher","first-page":"5556s","DOI":"10.1158\/1078-0432.CCR-07-1167","volume":"13","author":"R Stein","year":"2007","unstructured":"Stein R, Mattes MJ, Cardillo TM et al (2007) CD74: a\u00a0new candidate target for the immunotherapy of B\u2011cell neoplasms. Clin Cancer Res 13:5556s\u20135563s","journal-title":"Clin Cancer Res"},{"key":"4795_CR99","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1165\/rcmb.2010-0317OC","volume":"45","author":"L Tu","year":"2011","unstructured":"Tu L, Dewachter L, Gore B et al (2011) Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension. Am J Respir Cell Mol Biol 45:311\u2013322","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4795_CR100","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nm1567","volume":"13","author":"J Bernhagen","year":"2007","unstructured":"Bernhagen J, Krohn R, Lue H et\u00a0al (2007) MIF is a\u00a0noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13:587\u2013596","journal-title":"Nat Med"},{"key":"4795_CR101","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.mvr.2011.09.014","volume":"83","author":"B Zhang","year":"2012","unstructured":"Zhang B, Luo Y, Liu ML et\u00a0al (2012) Macrophage migration inhibitory factor contributes to hypoxic pulmonary vasoconstriction in rats. Microvasc Res 83:205\u2013212","journal-title":"Microvasc Res"},{"key":"4795_CR102","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2119\/molmed.2011.00094","volume":"18","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Talwar A, Tsang D et al (2012) Macrophage migration inhibitory factor mediates hypoxia-induced pulmonary hypertension. Mol Med 18:215\u2013223","journal-title":"Mol Med"},{"key":"4795_CR103","first-page":"840737","volume":"2012","author":"B Zhang","year":"2012","unstructured":"Zhang B, Shen M, Xu M et\u00a0al (2012) Role of macrophage migration inhibitory factor in the proliferation of smooth muscle cell in pulmonary hypertension. Mediators Inflamm 2012:840737","journal-title":"Mediators Inflamm."},{"key":"4795_CR104","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1021\/acs.jmedchem.7b01312","volume":"61","author":"M Le Hiress","year":"2018","unstructured":"Le Hiress M, Akagah B, Bernadat G et al (2018) Design, synthesis, and biological activity of new N\u2011(Phenylmethyl)-benzoxazol-2-thiones as macrophage Migration Inhibitory Factor (MIF) antagonists: efficacies in experimental pulmonary hypertension. J\u00a0Med Chem 61:2725\u20132736","journal-title":"J Med Chem"},{"key":"4795_CR105","doi-asserted-by":"publisher","first-page":"eaao4583","DOI":"10.1126\/scitranslmed.aao4583","volume":"9","author":"ED Michelakis","year":"2017","unstructured":"Michelakis ED, Gurtu V, Webster L et\u00a0al (2017) Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients. Sci Transl Med 9:eaao4583","journal-title":"Sci Transl Med"},{"key":"4795_CR106","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.cmet.2017.03.011","volume":"25","author":"L Calvier","year":"2017","unstructured":"Calvier L, Chouvarine P, Legchenko E et\u00a0al (2017) PPAR\u03b3 links BMP2 and TGF\u03b21 pathways in vascular smooth muscle cells, regulating cell proliferation and glucose metabolism. Cell Metab 25:1118\u20131134","journal-title":"Cell Metab"},{"key":"4795_CR107","doi-asserted-by":"publisher","first-page":"eaao0303","DOI":"10.1126\/scitranslmed.aao0303","volume":"10","author":"E Legchenko","year":"2018","unstructured":"Legchenko E, Chouvarine P, Borchert P et\u00a0al (2018) PPAR\u03b3 agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation. Sci Transl Med 10:eaao303","journal-title":"Sci Transl Med"},{"key":"4795_CR108","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1165\/rcmb.2013-0063OC","volume":"51","author":"A Klinke","year":"2014","unstructured":"Klinke A, M\u00f6ller A, Pekarova M et al (2014) Protective effects of 10-nitro-oleic acid in a\u00a0hypoxia-induced murine model of pulmonary hypertension. Am J Respir Cell Mol Biol 51:155\u2013162","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-019-4795-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-019-4795-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-019-4795-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T23:04:35Z","timestamp":1650150275000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-019-4795-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,7]]},"references-count":108,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["4795"],"URL":"https:\/\/doi.org\/10.1007\/s00059-019-4795-6","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,7]]},"assertion":[{"value":"7 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"E.M.\u00a0Berghausen, L.\u00a0Feik, M.\u00a0Zierden, M.\u00a0Vantler, and S.\u00a0Rosenkranz declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}